Hypergonadotropic hypogonadism.
Etiologic factors in hypergonadotropic hypogonadism are discussed. On the basis of these data a classification system is proposed for women with hypergonadotropic hypogonadism to be used in future investigations of the natural history of this disorder. The classification system can also be used in attempts at therapeutic intervention in these women. Recommendations for clinical management and future studies of women with hypergonadotropic hypogonadism are provided.
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D004958:Estradiol / Q000032:analysis; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007006:Hypogonadism / Q000145:classification* / Q000188:drug therapy / Q000209:etiology; D007247:Infertility, Female / Q000188:drug therapy / Q000209:etiology; D007621:Karyotyping; D008594:Menopause, Premature; D008596:Menotropins / Q000032:analysis*; D010049:Ovarian Diseases / Q000150:complications; D011829:Radiation Dosage
D000970:Antineoplastic Agents; D004967:Estrogens; D004958:Estradiol; D008596:Menotropins